Navigation Links
California Healthcare Institute Announces Executive Promotion
Date:4/22/2013

LA JOLLA, Calif. (PRWEB) April 22, 2013

The California Healthcare Institute (CHI) announced today the promotion of Holly Frisque, SPHR, to vice president of administration. Frisque, who has been with CHI since 2009, previously served as senior director of operations. CHI is a non-profit public policy research and advocacy organization for California’s biomedical R&D industry.

As vice president of administration, Frisque leads CHI in supervision of the human resources, communications, marketing, finance, membership services, corporate compliance and technology departments.

“For over four years, Holly’s leadership has contributed immensely to the positive direction and growth of CHI. This hard-earned promotion reflects CHI’s commitment to providing the highest level of member service and organizational management,” said CHI President and CEO David L. Gollaher, Ph.D. “Her diligence and professionalism will continue to make CHI a team-oriented and effective biomedical advocacy organization on behalf of our members.”

Frisque joined CHI as office manager of the La Jolla headquarters before being promoted to senior director of operations in 2012. Before joining CHI, Frisque served as the director of administration at Gizmo5 Technologies, Inc. and Linspire, Inc., two software development companies in San Diego. She also led administration for the biotech investment division of Enterprise Partners Venture Capital. Frisque has achieved the Senior Professional in Human Resources designation, reflecting her expertise in strategic management and highlighting her commitment to best practices. Frisque holds a bachelor's degree in psychology and a minor in creative writing from University of California, Riverside.

About CHI
CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepatitis C Infections
2. California Healthcare Institute Appoints Associate Director, Federal Government Relations and Programs
3. Executives from Johnson & Johnson, GlaxoSmithKline and California State Board of Pharmacy discuss pharmaceutical packaging challenges at Pharmapack North America 2013
4. Cellular Dynamics and Coriell Institute for Medical Research Awarded Multi-Million Dollar Grants from California Institute for Regenerative Medicine to Manufacture and Bank Stem Cell Lines
5. California Healthcare Institute Appoints Vice President-State Government Affairs
6. Genomas Expands Personalized Medicine Business with Clinical Laboratory Licenses in New York, Florida, California
7. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
8. JDRF and California Institute for Regenerative Medicine Increase Funding of ViaCyte
9. The California Healthcare Institute Responds to New Efforts to Repeal the Federal Medical Device Excise Tax
10. California Healthcare Institute Appoints Allergan CEO Chairman of the Board, Elects New Board Members
11. Precision Coating to Showcase Next Generation Coating Deposition Technology at MD&M West Show in Anaheim, California
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... VANCOUVER , Dec. 22, 2014 /PRNewswire/ - RepliCel ... stage regenerative medicine company focused on the development of ... paper out of the University of Calgary in conjunction ... North Carolina, which further validates the company,s ongoing clinical ... the effects of pattern baldness. The paper ...
(Date:12/22/2014)... The American Journal of ... research, reviews and editorials addressing developments and pathways ... published a provocative article exploring the role of ... potential treatment of prostate cancer. , The ... the possibility that there could be a connection ...
(Date:12/19/2014)... Charm Sciences is pleased to announce that ... Aflatoxin M1 in raw commingled milk is the first ... The peer reviewed report of the validation by Technology ... and Fisheries Research (ILVO-T&V) has been published by the ... most toxic aflatoxin and a known carcinogen, can be ...
(Date:12/19/2014)... , Dec. 19, 2014 Bina Technologies, Inc. ... announced today that they have been acquired by Roche ... is a privately held company that provides a big ... generation sequencing (NGS) data for the academic and translational ... Sequencing Unit, and will continue to focus on development ...
Breaking Biology Technology:Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... Products,Corp. (OTC Bulletin Board: TKER), a manufacturer and ... today,reported that it has installed its equipment to ... new plant operated by one of the,top 10 ... test of the,application to gauge its effectiveness, during ...
... Academy ... of Dermatology, FREEPORT, N.Y., Feb. 11 ... natural receptor,OCTN- 1, are a natural part of the skin,s antioxidant defense ... The data was presented at the Poster Session at the 66th Annual,Meeting ...
... Santaris Pharma, the,Danish biopharmaceutical company developing LNA based ... Chief Executive,Officer, will be presenting an overview of ... Biotechnology Industry Organisation,s 10th Annual CEO &,Investor Conference ... 12:30 pm,US Eastern Standard Time (18:30 Central European ...
Cached Biology Technology:Tasker Products Installs Scalder Application at New Poultry Processor's Facility 2Tasker Products Installs Scalder Application at New Poultry Processor's Facility 3AGI Dermatics Clinical Data Identifies L-Ergothioneine as Part of Skin's Natural Antioxidant System 2Santaris Pharma to Present at 10th Annual Biotechnology Industry Organisation CEO & Investor Conference - February 11th, 2008 2
(Date:12/19/2014)... 2014   LaunchKey , the first decentralized mobile ... Internet of Things era, today announced the close of ... was led by Metamorphic Ventures with participation from ENIAC ... and others.  LaunchKey has raised $4 million to date, ... team and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ... of the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major ... demand for medical sensors in biomedical applications. Chemical ... quick and correct diagnosis during surgical procedures. The ...
(Date:12/11/2014)...  That blood pressure plays a role in human health ... medical term for high blood pressure – was first described ... cuff that,s used in measuring blood pressure was invented in ... about hypertension, its triggers and its effects. In fact, recent ... the best ways to treat it. For example, ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... impact the world,s squid species, according to a new ... and soon to be published in the journal ... commercially important, that impact may have far-reaching effects on ... "Squid are at the center of the ocean ...
... the mantle of summer pest, cicadas are perhaps the most curious. ... head, they taste good in chocolate, but as the drowning din ... them less if they emerged more often. Cicadas are unique ... So why would anyone actually want to replicate theses sounds? ...
... Laboratory of Molecular Biology in the United Kingdom have determined ... that when mutated can lead to a hereditary form of ... EMBO Journal , define the position of many of the ... alterations may affect the stability and function of the protein. ...
Cached Biology News:Acidifying oceans could spell trouble for squid 2Acidifying oceans could spell trouble for squid 3Secrets of the cicada's sound 2Secrets of the cicada's sound 3How disease mutations affect the Parkin protein 2
... Goat polyclonal to Synaptogyrin ... all tested applications). ... CIYGEGYSNAHESKQ, corresponding to Internal sequence ... Synaptogyrin 2 ...
Rabbit polyclonal to SMURF 2 ( Abpromise for all tested applications). Antigen: A KLH conjugated synthetic peptide (10-30 aa in length) at the N-term of first 50 aa of human SMURF 2. Entrez G...
Rabbit polyclonal antibody to NCOA2 [Agarose Immobilized]...
Rabbit anti Mouse ZIC2 Preservative: NaN3...
Biology Products: